
Predicting the present What’s topping pharma’s strategic agenda for 2026?
Qinecsa Chief Operating Officer, John Cogan, has been featured in Pharma Times latest issue, where he predicts where is the industry setting its sights for

Qinecsa Chief Operating Officer, John Cogan, has been featured in Pharma Times latest issue, where he predicts where is the industry setting its sights for

London, UK – March 09th, 2026 – Qinecsa, the global class leader in technology-powered pharmacovigilance solutions, has announced the release of HaloPV 6.2, the latest update to its

Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, “How AI is Transforming the Biopharmaceutical Value Chain from Discovery to

The international success of GLP-1 agonists for weight loss is overwhelming pharma safety operations as they strive to monitor incoming adverse events, says Daniel O’keeffe

European Pharmaceutical Manufacturer spotlights Daniel O’Keeffe of Qinecsa Solutions in a recent article examining whether patient outcomes are being compromised by fragmented and inconsistent safety

In today’s increasingly complex pharmacovigilance landscape, organizations are re-evaluating how they structure their safety operations to remain compliant, agile, and future ready. Join safety expert
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she outlines how proactive PV, translational safety, AI foundations, and
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she explains how AI could revolutionize pharmacovigilance, if data, trust,
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she saw 2025 as an AI superposition in which pharmacovigilence
Qinecsa Chief Operating Officer, John Cogan, has been featured in The Pharma Navigator latest issue, where he discusses trends from 2025 for the bio/pharma industry.